Integrin Blockade
Integrin Blockade - Related Videos
01:10
Integrins
0 Views •
2023
Animal and protozoan cells do not have cell walls to help maintain shape and provide structural stability. Instead, these eukaryotic cells secrete a sticky mass of carbohydrates and proteins into the spaces between adjacent cells. This network of proteins and molecules is called an extracellular matrix or ECM. Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
01:29
Neuromuscular Junction And Blockade
0 Views •
2025
The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...
08:50
Deep Neuromuscular Blockade Leads to a Larger Intraabdominal Volume During Laparoscopy
0 Views •
Cited by 49 •
2013
This article presents a method for measuring the working abdominal volume during laproscopic myomectomy using the surgical grasper, and applies this technique to obtain pilot data on whether deep neuromuscular blockade (NMB) can enable the use of lower insufflation pressure. Reduced insufflation pressure during laproscopic surgery has been shown to reduce post-operative pain, and thus the use of NMB during surgery may enable improved patient outcomes.
01:15
Activation of Integrins
0 Views •
2023
Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling." In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
11:55
Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
0 Views •
Cited by 9 •
2011
This paper describes a simple technique to induce alloantigen-specific anergy in human peripheral blood mononuclear cells. The technique can be applied clinically to generate non-alloreactive donor cells. Infusion of these cells could improve immune reconstitution and reduce toxicity after allogeneic hematopoietic stem cell transplantation.
FAQs
Integrins connect adhesion with intracellular signaling, so blocking them can change more than whether a leukocyte attaches. Interfering with binding to extracellular-matrix proteins or counter-receptors may alter leukocyte migration, activation, and cell-cell contact at the same time. This makes blockade useful for examining coordinated immune responses rather than adhesion as an isolated event.
Blocking antibodies, peptides, and small-molecule antagonists provide distinct experimental formats for interrupting integrin binding. Their shared purpose is to prevent contact with extracellular-matrix proteins or counter-receptors, while different formats let investigators examine the same adhesion-dependent process through complementary perturbations. This helps determine whether altered immune-cell behavior follows loss of integrin-mediated contact and signaling.
In infection models, the key question may be whether an integrin primarily supports host-cell trafficking or contributes directly to pathogen interactions. A blockade experiment can examine immune-cell movement toward infected tissues, inflammatory regulation, and possible pathogen attachment or cellular entry. Separating these readouts helps connect integrin activity with the host response, the infection process, or both.
A practical study begins by identifying the integrin-mediated interaction under investigation and selecting a blocking antibody, peptide, or small-molecule antagonist. Researchers then assess consequences for the relevant response, such as adhesion, signaling, migration, activation, or cell-cell contact. This workflow links a defined molecular interruption to a measurable immune or infection-related outcome without assuming that every integrin has the same role.
When the research focus is inflammation, Integrin Blockade can test how adhesion and signaling contribute to immune-response regulation. In infection studies, it can help determine whether immune cells reach infected tissues and whether integrin interactions participate in pathogen attachment or cellular entry. These applications make the approach a mechanistic tool for connecting cell interactions with disease-related processes.
Results can support evaluation of integrins as targets for anti-inflammatory or antimicrobial intervention. A change in leukocyte trafficking, activation, inflammatory regulation, pathogen attachment, or cellular entry identifies a disease-related process associated with integrin function. Such findings clarify mechanisms and indicate which interaction may warrant further investigation, while remaining experimental evidence rather than proof of therapeutic success.